These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16298006)

  • 1. Experimental and modelling study of different process modes for retroviral production in a fixed bed reactor.
    Nehring D; Gonzalez R; Pörtner R; Czermak P
    J Biotechnol; 2006 Mar; 122(2):239-53. PubMed ID: 16298006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling retrovirus production for gene therapy. 1. Determination Of optimal bioreaction mode and harvest strategy.
    Cruz PE; Almeida JS; Murphy PN; Moreira JL; Carrondo MJ
    Biotechnol Prog; 2000; 16(2):213-21. PubMed ID: 10753446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of different bioreactor systems for the production of high titer retroviral vectors.
    Merten OW; Cruz PE; Rochette C; Geny-Fiamma C; Bouquet C; Gonçalves D; Danos O; Carrondo MJ
    Biotechnol Prog; 2001; 17(2):326-35. PubMed ID: 11312711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor.
    Ghani K; Garnier A; Coelho H; Transfiguracion J; Trudel P; Kamen A
    Biotechnol Bioeng; 2006 Nov; 95(4):653-60. PubMed ID: 16947907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Closed hollow-fiber bioreactor: a new approach to retroviral vector production.
    Pan D; Whitley CB
    J Gene Med; 1999; 1(6):433-40. PubMed ID: 10753069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
    Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
    J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-titer adenovirus vector production in 293S cell perfusion culture.
    Cortin V; Thibault J; Jacob D; Garnier A
    Biotechnol Prog; 2004; 20(3):858-63. PubMed ID: 15176892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of a mammalian cell culture process by adaptive, model-based dialysis fed-batch cultivation and suppression of apoptosis.
    Frahm B; Lane P; Märkl H; Pörtner R
    Bioprocess Biosyst Eng; 2003 Nov; 26(1):1-10. PubMed ID: 14505167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mathematical modelling of a mixed culture cultivation process for the production of polyhydroxybutyrate.
    Dias JM; Serafim LS; Lemos PC; Reis MA; Oliveira R
    Biotechnol Bioeng; 2005 Oct; 92(2):209-22. PubMed ID: 15991238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput screening of Hansenula polymorpha clones in the batch compared with the controlled-release fed-batch mode on a small scale.
    Scheidle M; Jeude M; Dittrich B; Denter S; Kensy F; Suckow M; Klee D; Büchs J
    FEMS Yeast Res; 2010 Feb; 10(1):83-92. PubMed ID: 19849718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State-of-the-art of the production of retroviral vectors.
    Merten OW
    J Gene Med; 2004 Feb; 6 Suppl 1():S105-24. PubMed ID: 14978755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using a fed-batch culture strategy to enhance rAAV production in the baculovirus/insect cell system.
    Liu YK; Yang CJ; Liu CL; Shen CR; Shiau LD
    J Biosci Bioeng; 2010 Aug; 110(2):187-93. PubMed ID: 20547323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine and HIV-based retroviral vectors for in vitro and in vivo gene transfer.
    Alfa RW; Blesch A
    Methods Mol Med; 2006; 129():241-54. PubMed ID: 17085815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphologically structured model for antitumoral retamycin production during batch and fed-batch cultivations of Streptomyces olindensis.
    Giudici R; Pamboukian CR; Facciotti MC
    Biotechnol Bioeng; 2004 May; 86(4):414-24. PubMed ID: 15112294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of medium sugar source on the production of retroviral vectors for gene therapy.
    Coroadinha AS; Ribeiro J; Roldão A; Cruz PE; Alves PM; Merten OW; Carrondo MJ
    Biotechnol Bioeng; 2006 May; 94(1):24-36. PubMed ID: 16514678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization for high-density cultivation of heterotrophic Chlorella based on a hybrid neural network model.
    Wu Z; Shi X
    Lett Appl Microbiol; 2007 Jan; 44(1):13-8. PubMed ID: 17209808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioreactor production of recombinant herpes simplex virus vectors.
    Knop DR; Harrell H
    Biotechnol Prog; 2007; 23(3):715-21. PubMed ID: 17461549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling of Xanthophyllomyces dendrorhous growth on glucose and overflow metabolism in batch and fed-batch cultures for astaxanthin production.
    Liu YS; Wu JY
    Biotechnol Bioeng; 2008 Dec; 101(5):996-1004. PubMed ID: 18683256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simpler noninstrumented batch and semicontinuous cultures provide mammalian cell kinetic data comparable to continuous and perfusion cultures.
    Henry O; Kwok E; Piret JM
    Biotechnol Prog; 2008; 24(4):921-31. PubMed ID: 19194901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On-line purification of monoclonal antibodies using an integrated stirred-tank reactor/expanded-bed adsorption system.
    Ohashi R; Otero JM; Chwistek A; Yamato I; Hamel JF
    Biotechnol Prog; 2002; 18(6):1292-300. PubMed ID: 12467465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.